Cited 4 times in
2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y1 2 Receptor Antagonists in the Asia-Pacific Region: Special Populations
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김병극 | - |
dc.contributor.author | 김중선 | - |
dc.date.accessioned | 2022-09-14T01:47:41Z | - |
dc.date.available | 2022-09-14T01:47:41Z | - |
dc.date.issued | 2021-11 | - |
dc.identifier.issn | 1758-3756 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/190613 | - |
dc.description.abstract | Advanced age, diabetes, and chronic kidney disease not only increase the risk for ischaemic events in chronic coronary syndromes (CCS) but also confer a high bleeding risk during antiplatelet therapy. These special populations may warrant modification of therapy, especially among Asians, who have displayed characteristics that are clinically distinct from Western patients. Previous guidance has been provided regarding the classification of high-risk CCS and the use of newer-generation P2Y12 inhibitors (i.e. ticagrelor and prasugrel) after acute coronary syndromes (ACS) in Asia. The authors summarise evidence on the use of these P2Y12 inhibitors during the transition from ACS to CCS and among special populations. Specifically, they present recommendations on the roles of standard dual antiplatelet therapy, shortened dual antiplatelet therapy and single antiplatelet therapy among patients with coronary artery disease, who are either transitioning from ACS to CCS; elderly; or with chronic kidney disease, diabetes, multivessel coronary artery disease and bleeding events during therapy. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Radcliffe Cardiology | - |
dc.relation.isPartOf | EUROPEAN CARDIOLOGY REVIEW | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | 2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y1 2 Receptor Antagonists in the Asia-Pacific Region: Special Populations | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Jack Wei Chieh Tan | - |
dc.contributor.googleauthor | Derek P Chew | - |
dc.contributor.googleauthor | Kin Lam Tsui | - |
dc.contributor.googleauthor | Doreen Tan | - |
dc.contributor.googleauthor | Dmitry Duplyakov | - |
dc.contributor.googleauthor | Ayman Hammoudeh | - |
dc.contributor.googleauthor | Bo Zhang | - |
dc.contributor.googleauthor | Yi Li | - |
dc.contributor.googleauthor | Kai Xu | - |
dc.contributor.googleauthor | Paul J Ong | - |
dc.contributor.googleauthor | Doni Firman | - |
dc.contributor.googleauthor | Habib Gamra | - |
dc.contributor.googleauthor | Wael Almahmeed | - |
dc.contributor.googleauthor | Jamshed Dalal | - |
dc.contributor.googleauthor | Li-Wah Tam | - |
dc.contributor.googleauthor | Gabriel Steg | - |
dc.contributor.googleauthor | Quang N Nguyen | - |
dc.contributor.googleauthor | Junya Ako | - |
dc.contributor.googleauthor | Jassim Al Suwaidi | - |
dc.contributor.googleauthor | Mark Chan | - |
dc.contributor.googleauthor | Mohamed Sobhy | - |
dc.contributor.googleauthor | Abdulla Shehab | - |
dc.contributor.googleauthor | Wacin Buddhari | - |
dc.contributor.googleauthor | Zulu Wang | - |
dc.contributor.googleauthor | Alan Yean Yip Fong | - |
dc.contributor.googleauthor | Bilgehan Karadag | - |
dc.contributor.googleauthor | Byeong-Keuk Kim | - |
dc.contributor.googleauthor | Usman Baber | - |
dc.contributor.googleauthor | Chee Tang Chin | - |
dc.contributor.googleauthor | Ya Ling Han | - |
dc.identifier.doi | 10.15420/ecr.2021.35 | - |
dc.contributor.localId | A00493 | - |
dc.contributor.localId | A00961 | - |
dc.relation.journalcode | J04068 | - |
dc.identifier.eissn | 1758-3764 | - |
dc.identifier.pmid | 34815751 | - |
dc.subject.keyword | Asia | - |
dc.subject.keyword | Platelet aggregation inhibitors | - |
dc.subject.keyword | comorbidity | - |
dc.subject.keyword | consensus | - |
dc.subject.keyword | dual antiplatelet therapy | - |
dc.subject.keyword | myocardial ischaemia | - |
dc.contributor.alternativeName | Kim, Byeong Keuk | - |
dc.contributor.affiliatedAuthor | 김병극 | - |
dc.contributor.affiliatedAuthor | 김중선 | - |
dc.citation.volume | 16 | - |
dc.citation.startPage | e43 | - |
dc.identifier.bibliographicCitation | EUROPEAN CARDIOLOGY REVIEW, Vol.16 : e43, 2021-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.